Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results
01 juil. 2020 17h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 01, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading global point-of-care diagnostic company focused on infectious diseases, today announced today...
Chembio Diagnostics Receives FDA 510(k) Clearance for DPP Zika IgM System
08 juin 2020 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., June 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has...
Chembio Diagnostics Strengthens Commercial Organization
02 juin 2020 08h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., June 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that Chuck...
Chembio Diagnostics to Participate in Upcoming Investor Conferences
26 mai 2020 16h15 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 26, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the company...
Chembio Diagnostics Announces US Distribution Agreement to Expand Reach of DPP COVID-19 Serological Test with Thermo Fisher Scientific’s Healthcare Channel
18 mai 2020 07h00 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 18, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has signed a...
Chembio Diagnostics Announces Closing of Public Offering of Common Stock
11 mai 2020 10h20 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the...
Chembio Diagnostics Announces Pricing of Public Offering of Common Stock
07 mai 2020 08h55 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 07, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the...
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
06 mai 2020 16h01 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today a...
Chembio Diagnostics Reports First Quarter 2020 Financial Results
04 mai 2020 16h05 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics Attains CE Marking for DPP COVID-19 System for IgG and IgM Antibodies
04 mai 2020 16h04 HE
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has attained...